India Digital Diabetes Management Market
India Digital Diabetes Management Market - By Product (Smart Glucose Meter, Continuous Blood Glucose Monitoring System, Smart Insulin Pens, Smart Insulin Pumps, Apps); By Device (Wearable Devices, Handheld Devices); By End Use (Hospitals, Home Settings, Diagnostic Centers); By Region (North India, South India, East India, West India), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
- Published Date: May 2023
- Report ID: BWC23435
- Available Format: PDF
- Page: 200
Report Overview
Advent of artificial intelligence (AI) in diabetes care devices and an increasing number of diabetes patients are expected to boost the growth of India digital diabetes management market during the forecast period between 2023 and 2029.
India Digital Diabetes Management Market - Industry Trends & Forecast Report, 2029
India digital diabetes management market size was estimated to be worth USD 477.06 million in 2022. During the forecast period between 2023 and 2029, the India digital diabetes management market size is projected to grow at a CAGR of 12.99% reaching a value of USD 1,114 million by 2029. Major growth factors for the India digital diabetes management market include the rising prevalence of diabetes as well as the increasing adoption of advanced technologies such as smartwatches for better management of chronic illnesses. The expanding number of indigenous healthcare companies and brands offering digital diabetes management is anticipated to provide lucrative growth opportunities to the India digital diabetes management market.
India Digital Diabetes Management Market – Overview
According to the definition by the World Health Organization (WHO), diabetes is a chronic condition brought on by either insufficient insulin production by the pancreas or inefficient insulin utilization by the body. A hormone called insulin controls blood sugar levels. The following six technologies have the potential to revolutionize diabetes care: telehealth, qualitative hypoglycemia alarms, artificial intelligence, cybersecurity of diabetes devices, diabetes registries, and the incorporation of digital diabetes data into the electronic health record.
India Digital Diabetes Management Market
Growth Drivers
Increasing Prevalence of Diabetes
According to the data by the World Health Organization (WHO), diabetes prevalence in India increased from 7.1% in 2009 to 8.9% in 2019. Nearly 25 million Indians over the age of 18 are prediabetics (at an increased risk of getting diabetes in the near future), and it is estimated that 77 million people over that age have type 2 diabetes in India. When diabetes is not identified and treated promptly, more than 50% of people experience health issues. These factors are anticipated to increase the demand for digital diabetes management and promote overall market expansion during the forecast period.
Restraints
High Cybersecurity Risks and Chances of Inaccurate Data
One of the main issues with wearables is the confidentiality and privacy of medical records. Wearable technology continuously gathers, stores, transfers, and handles health information, raising questions about security and protection. The gathered information is disseminated digitally, online, or with other parties who might use it for marketing. Other limitations of wearable technology include data validity, reliability, and accuracy. If the gadget is worn on various body areas and varies depending on the device, the data collected may vary substantially. To diagnose symptoms or provide direct therapy, erroneous data is never acceptable.
Impact of COVID-19 on the India Digital Diabetes Management Market
The unprecedented COVID-19 pandemic offered immense growth opportunities to the India digital diabetes management market. Several studies conducted during the pandemic revealed that diabetes patients are more prone to get severe COVID-19 conditions. The pancreas, which is the organ that produces insulin, may be directly attacked by COVID. Blood glucose (sugar) levels may rise and the body's metabolic pathways for metabolizing glucose may shift as a result of inflammation in the body during COVID. However, patient visits to healthcare facilities during the lockdown declined owing to the high risk of cross-contamination. This resulted in a significant spike in digital diabetes management technologies for better remote patient monitoring.
India Digital Diabetes Management Market
Segmental Coverage
India Digital Diabetes Management Market – By Product
Based on the product, the India digital diabetes management market is divided into smart glucose meters, continuous blood glucose monitoring systems, smart insulin pens, smart insulin pumps, and apps segments. The apps segment is further categorized into digital diabetes management apps and weight & diet management apps. The continuous blood glucose monitoring system segment holds the highest market share in the India digital diabetes management market, owing to its modern features, which include connectivity with smart gadgets that act as display devices.
India Digital Diabetes Management Market – By Device
Based on devices, the India digital diabetes management market is split into wearable devices and handheld devices segments. The wearable devices segment accounts for a higher market share. Diabetes patients can more easily adhere to medical professionals' recommendations with wearable technology and healthcare IoT applications. Healthcare professionals can more objectively and successfully treat changes in their patients' illnesses by ensuring that medication is taken as prescribed. With the help of wearable technology, patients can obtain the information they require without fumbling over with phones or laptops, which plays a crucial factor in propelling its market growth.
India Digital Diabetes Management Market – By End Use
Based on end use, the India digital diabetes management market is segmented into hospitals, home settings, and diagnostic centers. The home settings segment accounts for the highest market share, as these digital diabetes management technologies allow diabetes patients and caregivers to manage their illnesses efficiently in the absence of medical professionals. The use of digital diabetes management devices and apps helps patients take their doses routinely as well as constantly track their glucose levels to eliminate the risk of emergencies.
India Digital Diabetes Management Market – By Region
The in-depth research report on the India digital diabetes management market covers four major regions: North India, South India, East India, and West India. South India dominates the India digital diabetes management market, owing to the high rate of the condition in the region. According to a study by Medical Sciences and Technology, Thiruvananthapuram, and the Indian Council of Medical Research, Kerala has the largest number of diabetes patients followed by Punjab and Tamil Nadu with 19.4%, 13.6%, and 10% respectively. The high accessibility to healthcare services compared to other states also plays a crucial factor in propelling the market growth in South India.
Competitive Landscape
Major players operating in India digital diabetes management market include Abbott Laboratories, Medtronic plc, F. Hoffmann-La Roche Ltd., Bayer AG, Lifescan, Inc., Dexcom, Inc., Sanofi, Insulet Corporation, Ascensia Diabetes Care Holdings Ag, and B Braun Melsungen AG.
These companies employ various strategies to further enhance their market share, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
Recent Developments
-
In March 2023 – Becton Dickinson India released a BD Diabetes Care app featuring digital tools and diabetes content for medical professionals, carers, and patients with diabetes.
Scope of the Report
Attributes |
Details |
Years Considered |
Historical Data – 2019–2022 |
Base Year – 2022 |
|
Estimated Year – 2023 |
|
Forecast Period – 2023–2029 |
|
Facts Covered |
Revenue in USD Million |
Market Coverage |
North India, South India, East India, West India |
Product/ Service Segmentation |
Product, Device, End Use, Region |
Key Players |
Abbott Laboratories, Medtronic plc, F. Hoffmann-La Roche Ltd., Bayer AG, Lifescan, Inc., Dexcom, Inc., Sanofi, Insulet Corporation, Ascensia Diabetes Care Holdings Ag, B Braun Melsungen AG |
By Product
-
Smart Glucose Meter
-
Continuous Blood Glucose Monitoring System
-
Smart Insulin Pens
-
Smart Insulin Pumps
-
Apps
-
Digital Diabetes Management Apps
-
Weight & Diet Management Apps
By Device
-
Wearable Devices
-
Handheld Devices
By End Use
-
Hospitals
-
Home settings
-
Diagnostic Centers
By Region
-
North India
-
South India
-
East India
-
West India
- Research Framework
- Research Objective
- Product Overview
- Market Segmentation
- Executive Summary
- India Digital Diabetes Management Market Insights
- Industry Value Chain Analysis
- DROC Analysis
- Growth Drivers
- Advent of Artificial Intelligence in Diabetes Care Devices
- Increasing Number of Diabetes Patients
- Restraints
- High Cost of Devices
- Opportunity
- Increasing Awareness About Diabetes Preventive Care
- Challenges
- Lack of Data Security
- Growth Drivers
- Technology Advancements/Recent Developments
- Regulatory Framework
- Porter’s Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of New Entrants
- Threat of Substitutes
- Intensity of Rivalry
- India Digital Diabetes Management Market Overview
- Market Size & Forecast, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Product
- Smart Glucose Meter
- Continuous Blood Glucose Monitoring System
- Smart Insulin Pens
- Smart Insulin Pumps
- Apps
- Digital Diabetes Management Apps
- Weight & Diet Management Apps
- By Device
- Wearable Devices
- Handheld Devices
- By End Use
- Hospitals
- Home settings
- Diagnostic Centers
- By Region
- North India
- South India
- East India
- West India
- By Product
- Market Size & Forecast, 2019–2029
- North India Digital Diabetes Management Market
- Market Size & Forecast, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Product
- By Device
- By End Use
- Market Size & Forecast, 2019–2029
- South India Digital Diabetes Management Market
- Market Size & Forecast, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Product
- By Device
- By End Use
- Market Size & Forecast, 2019–2029
- East India Digital Diabetes Management Market
- Market Size & Forecast, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Product
- By Device
- By End Use
- Market Size & Forecast, 2019–2029
- West India Digital Diabetes Management Market
- Market Size & Forecast, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Product
- By Device
- By End Use
- Market Size & Forecast, 2019–2029
- Competitive Landscape
- List of Key Players and Their Offerings
- India Digital Diabetes Management Company Market Share Analysis, 2022
- Competitive Benchmarking, By Operating Parameters
- Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
- Impact of Covid-19 on India Digital Diabetes Management Market
- Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
- Abbott Laboratories
- Medtronic plc
- F. Hoffmann-La Roche Ltd.
- Bayer AG
- Lifescan, Inc.
- Dexcom, Inc.
- Sanofi
- Insulet Corporation
- Ascensia Diabetes Care Holdings AG
- B Braun Melsungen AG
- Other Prominent Players
- Key Strategic Recommendations
- Research Methodology
- Qualitative Research
- Primary & Secondary Research
- Quantitative Research
- Market Breakdown & Data Triangulation
- Secondary Research
- Primary Research
- Breakdown of Primary Research Respondents, By Region
- Assumptions & Limitations
- Qualitative Research
*Financial information of case of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.
List of Figures
Figure 1 India Digital Diabetes Management Segmentation
Figure 2 India Digital Diabetes Management Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2022
Figure 4 India Digital Diabetes Management Market Size, By Value (USD Million), 2019–2029
Figure 5 India Digital Diabetes Management Market Share, By Product, By Value, 2019–2029
Figure 6 India Digital Diabetes Management Market Share, By Device, By Value, 2019–2029
Figure 7 India Digital Diabetes Management Market Share, By End Use, By Value, 2019–2029
Figure 8 North India Digital Diabetes Management Market Size, By Value (USD Million), 2019–2029
Figure 9 North India Digital Diabetes Management Market Share, By Product, By Value, 2019–2029
Figure 10 North India Digital Diabetes Management Market Share, By Device, By Value, 2019–2029
Figure 11 North India Digital Diabetes Management Market Share, By End Use, By Value, 2019–2029
Figure 12 South India Digital Diabetes Management Market Size, By Value (USD Million), 2019–2029
Figure 13 South India Digital Diabetes Management Market Share, By Product, By Value, 2019–2029
Figure 14 South India Digital Diabetes Management Market Share, By Device, By Value, 2019–2029
Figure 15 South India Digital Diabetes Management Market Share, By End Use, By Value, 2019–2029
Figure 16 East India Digital Diabetes Management Market Size, By Value (USD Million), 2019–2029
Figure 17 East India Digital Diabetes Management Market Share, By Product, By Value, 2019–2029
Figure 18 East India Digital Diabetes Management Market Share, By Device, By Value, 2019–2029
Figure 19 East India Digital Diabetes Management Market Share, By End Use, By Value, 2019–2029
Figure 20 West India Digital Diabetes Management Market Size, By Value (USD Million), 2019–2029
Figure 21 West India Digital Diabetes Management Market Share, By Product, By Value, 2019–2029
Figure 22 West India Digital Diabetes Management Market Share, By Device, By Value, 2019–2029
Figure 23 West India Digital Diabetes Management Market Share, By End Use, By Value, 2019–2029
List of Tables
Table 1 India Digital Diabetes Management Market Size, By Value (USD Million), 2019–2029
Table 2 India Digital Diabetes Management Market Size, By Product, By Value, 2019–2029
Table 3 India Digital Diabetes Management Market Size, By Device, By Value, 2019–2029
Table 4 India Digital Diabetes Management Market Size, By End Use, By Value, 2019–2029
Table 5 North India Digital Diabetes Management Market Size, By Value (USD Million), 2019–2029
Table 6 North India Digital Diabetes Management Market Size, By Product, By Value, 2019–2029
Table 7 North India Digital Diabetes Management Market Size, By Device, By Value, 2019–2029
Table 8 North India Digital Diabetes Management Market Size, By End Use, By Value, 2019–2029
Table 9 South India Digital Diabetes Management Market Size, By Value (USD Million), 2019–2029
Table 10 South India Digital Diabetes Management Market Size, By Product, By Value, 2019–2029
Table 11 South India Digital Diabetes Management Market Size, By Device, By Value, 2019–2029
Table 12 South India Digital Diabetes Management Market Size, By End Use, By Value, 2019–2029
Table 13 East India Digital Diabetes Management Market Size, By Value (USD Million), 2019–2029
Table 14 East India Digital Diabetes Management Market Size, By Product, By Value, 2019–2029
Table 15 East India Digital Diabetes Management Market Size, By Device, By Value, 2019–2029
Table 16 East India Digital Diabetes Management Market Size, By End Use, By Value, 2019–2029
Table 17 West India Digital Diabetes Management Market Size, By Value (USD Million), 2019–2029
Table 18 West India Digital Diabetes Management Market Size, By Product, By Value, 2019–2029
Table 19 West India Digital Diabetes Management Market Size, By Device, By Value, 2019–2029
Table 20 West India Digital Diabetes Management Market Size, By End Use, By Value, 2019–2029
Table 21 Abbott Laboratories Company Overview
Table 22 Abbott Laboratories Financial Overview
Table 23 Medtronic plc Company Overview
Table 24 Medtronic plc Financial Overview
Table 25 F. Hoffmann-La Roche Ltd. Company Overview
Table 26 F. Hoffmann-La Roche Ltd. Financial Overview
Table 27 Bayer AG Company Overview
Table 28 Bayer AG Financial Overview
Table 29 Lifescan, Inc. Company Overview
Table 30 Lifescan, Inc. Financial Overview
Table 31 Dexcom, Inc. Company Overview
Table 32 Dexcom, Inc. Financial Overview
Table 33 Sanofi Company Overview
Table 34 Sanofi Financial Overview
Table 35 Insulet Corporation Company Overview
Table 36 Insulet Corporation Financial Overview
Table 37 Ascensia Diabetes Care Holdings AG Company Overview
Table 38 Ascensia Diabetes Care Holdings AG Financial Overview
Table 39 B Braun Melsungen AG Company Overview
Table 40 B Braun Melsungen AG Financial Overview
Market Segmentation
To request a free sample copy of this report, please complete the form below.
We value your investment and offer free customization with every report to fulfil your exact research needs.
Frequently Asked Questions (FAQs):
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research Support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Custom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.